Brief: Neubase Therapeutics Announces Issuance Of A Foundational Patent
17/10/2019 13:16
Oct 17 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS ANNOUNCES ISSUANCE OF FOUNDATIONAL
PATENT
COVERING THE KEY BUILDING BLOCKS OF PATROL ENABLED THERAPIES
Source text for Eikon: ID:nGNXcf5G0P
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet